0000899243-22-018133.txt : 20220516
0000899243-22-018133.hdr.sgml : 20220516
20220516161019
ACCESSION NUMBER: 0000899243-22-018133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mamluk Roni
CENTRAL INDEX KEY: 0001647053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 22929025
MAIL ADDRESS:
STREET 1: CHIASMA, INC.
STREET 2: 60WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-16
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001647053
Mamluk Roni
OPPENHEIMER 4
REHOVOT
L3
7670104
ISRAEL
1
1
0
0
President & CEO
Common Stock
2022-05-16
4
A
0
120000
0.00
A
265345
D
Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.
/s/ Roni Mamluk, Ph.D.
2022-05-16